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OBJECTIVES: To determine whether delivery of better
quality of care for urinary incontinence (UI) and falls is
associated with better participant-reported outcomes.
DESIGN: Retrospective cohort study.
SETTING: Assessing Care of Vulnerable Elders Study 2
(ACOVE-2).
PARTICIPANTS: Older (75) ambulatory care partici-
pants in ACOVE-2 who screened positive for UI (n 5 133)
or falls or fear of falling (n 5 328).
MEASUREMENTS: Composite quality scores (percentage
of quality indicators (QIs) passed per participant) and change
in Incontinence Quality of Life (IQOL, range 0–100) or Falls
Efficacy Scale (FES, range 10–40) scores were measured
before and after care was delivered (mean 10 months). Because
the treatment-related falls QIs were measured only on patients
who received a physical examination, an alternative Common
Pathway QI (CPQI) score was developed that assigned a failing
score for falls treatment to unexamined participants.
RESULTS: Each 10% increment in receipt of recommended
care for UI was associated with a 1.4-point improvement in
IQOL score (P 5.01). The original falls composite quality-
of-care score was unrelated to FES, but the new CPQI scoring
method for falls quality of care was related to FES outcomes
(10.4 points per 10% increment in falls quality, P 5.01).
CONCLUSION: Better quality of care for falls and UI was
associated with measurable improvement in participant-
reported outcomes in less than 1 year. The connection be-
tween process and outcome required consideration of
the interdependence between diagnosis and treatment in
the falls QIs. The link between process and outcome dem-
onstrated for UI and falls underscores the importance of
improving care in these areas. J Am Geriatr Soc 59:1435–
1443, 2011.
Key words: quality of care; urinary incontinence; falls
Urinary incontinence (UI) and falls are prevalent geri-atric conditions1–4 and are associated with disability,
morbidity, and poor quality of life.2,5–7 Despite the avail-
ability of effective treatments to improve UI and reduce the
risk of falling,7–16 delivery of recommended care for these
conditions in primary care settings is poor.17,18
The Assessing the Care of Vulnerable Elders Study 2
(ACOVE-2) was a controlled trial of an intervention to in-
crease adherence to evidence- and consensus-based processes
of care for three geriatric conditions (UI, falls, and dementia).
The primary outcome of ACOVE-2 was the group-level score
on 18 process-of-care indicators spanning these three condi-
tions. The ACOVE-2 intervention was associated with mod-
erate improvements in quality of care for falls (44% vs 23% of
recommended care delivered for the intervention vs control
site) and UI (37% vs 22%).19 Although ACOVE-2 was not
designed to study clinical outcomes, participants were also
given condition-specific symptom inventories for UI (the In-
continence Quality of Life (IQOL) survey20) and falls (fear of
falling measured using the Falls Efficacy Scale (FES)21) before
and after the quality improvement intervention was imple-
mented. This article presents a secondary analysis that exam-
ines the relationship between quality of care delivered during
ACOVE-2 and these participant-reported outcomes. It
was hypothesized that delivering more recommended care
processes to participants with UI and falls would result in




ACOVE-2 enrolled 649 participants (aged75) to test a
multicomponent intervention to improve quality of care for
UI, falls, and dementia.19 The intervention, which consisted
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of physician education, structured visit notes that guided
physicians to provide recommended care, and community
resource and education handouts for participants,22 was
implemented at two large medical practices in southern
California (each with intervention and control sites). Insti-
tutional review boards at RAND, the University of Cali-
fornia at Los Angeles, and the Greater Los Angeles Veterans
Affairs Healthcare System approved the research protocol.
Before appointments at intervention and control sites,
all individuals aged 75 and older (n 5 2,671, Figure 1) were
screened for UI and falls during a 13-month observation
window in 2002/03. The screening questions, administered
by office personnel, asked: Do you have a problem with UI
(or your bladder) that is bothersome enough that you would
like to know more about how it could be treated?’’ and ‘‘In
the past 12 months, have you fallen 2 or more times? . . .
fallen and hurt yourself or needed to see a doctor because of
a fall? . . . or been afraid that you would fall because of
balance or walking problems?’’ Participants who screened
positive for UI answered the IQOL survey, a measure of
incontinence-related quality of life associated with clinical
incontinence severity.20,23 Those who screened positive
for falls or fear of falling (answering yes to any of the
three questions) were administered the FES,21 a measure of
concern about falling during daily activities that is associ-
ated with future falls, gait and balance impairment, and
disability.8,21,24–26
At study completion, participants were readministered
the IQOL and FES survey. The analysis included partici-
pants who completed pre- and postsurveys. Participant
2,671 patients aged ≥ 75 with appointments
at two large multispecialty practices
235 (9%) screened
positive for new or
bothersome UI
symptoms 
203 (86%) with 
baseline IQOL 
30 (18%) excluded from
           evaluation of UI QIs: 
     11 (7%) maximally treated for  
           UI 
      8 (5%) documented denial of  
           UI symptoms 
      5 (3%) with UTI 
      3 (2%) outside urology  
            records not available 
      3 (2%) already started on UI  
           treatment 
32 (14%) excluded from analysis: 
    28 (12%) unable to self-report 
     4 (2%) with incomplete IQOL 
133 (82%) evaluated for UI 
quality using 650 QIs
500 (19%) screened 
positive for falls or fear of 
falling: 53 (11%) with falls 
only, 369 (74%) with fear 
of falling only,  
78 (16%) with both 
411 (82%) with 
baseline FES 
17 (5%) excluded from evaluation
            of falls QIs: 
      11 (3%) maximally treated for  
           falls 
      3 (1%) documented denial of  
           fear of falling 
      2 (<1%) false positive screens
           for fear of falling 
      1 (<1%) incomplete medical  
            records 
89 (18%) excluded from analysis: 
    81 (16%) unable to self-report 
     8 (2%) with incomplete FES 
328 (95%) evaluated for 
falls quality using:
40 (20%) with incomplete 
or missing follow-up IQOL 
163 (80%) with both 
IQOL surveys
66 (16%) with incomplete 
or missing follow-up FES
345 (84%) with 
both FES surveys
579 falls QIs via 
original ACOVE-2 
scoring method 
808 falls QIs via 
alternative scoring 
method**
Figure 1. Enrollment and quality-of-care measurement for falls and urinary incontinence in participants in the Assessing the Care of
Vulnerable Elders Study (ACOVE-2). Participants with positive screens for urinary incontinence (UI) and falls were considered in
both samples. There were 115 (4.3% of screened sample of 2,671) with positive UI and falls or fear of falling screens. After exclusions,
the final analytical sample included 55 participants who screened positive for both conditions (17% of the falls sample and 41% of the
UI sample). The original scoring method did not evaluate whether appropriate treatment was delivered to 241 participants who
were not examined for falls or fear of falling. The Common Pathway Quality Indicator (CPQI) scoring method assumes that
participants with no examination documentation had an abnormal examination and evaluates treatment for these participants.
FES 5 Falls Efficacy Scale; IQOL 5 Incontinence Quality of Life Survey; QI 5 Quality indicator; UTI 5 Urinary tract infection.
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characteristics are summarized in Table 1. Participants who
participated in the study for both conditions were included
in both analyses.
Outcome Variables
The outcome variable for the UI analysis was change in
severity of UI symptoms as measured according to the
IQOL survey.23,27 The overall IQOL score ranges from 0 to
100 points, with higher scores representing better quality of
life (milder symptoms). The overall IQOL is calculated as
the sum of 22 questions scored on a 5-point scale, each item
ranging from extremely symptomatic (1 point) to not at all
(5 points), followed by rescaling to the 100-point range.
Subscores representing three subdomains of incontinence-
related quality of life are also calculated using subsets of the
items (also followed by rescaling to 0–100): avoidance and
limiting behavior (e.g., ‘‘I worry where the toilets are in new
places’’), social embarrassment (e.g., ‘‘I worry about wet-
ting myself’’), and psychosocial consequences (e.g., ‘‘I feel
depressed because of UI problems’’).20 The analytical sam-
ple included subjects with three or fewer missing items.
Multiple imputation (ordered logit models, 5 imputations
with recombination of 5 data sets for all analyses) were used
to obtain complete IQOL scores for 13 baseline interviews
and four follow-up interviews with three or fewer missing
items.28 Change scores were computed by subtracting the
baseline IQOL score from the follow-up IQOL score. Because
higher IQOL scores represent less-severe disease, a positive
change in score represents improvement in the UI condition
over time. In this study, a 2-point improvement in IQOL score
was considered to be the minimally important effect size. In a
prior study of the effect of duloxetine on UI, participants who
perceived their overall change in symptoms as a little better,
much better, or very much better had mean IQOL change
scores of 2, 6, and 13 points, respectively. Those who
reported a substantial improvement in incontinent episodes
per day (25% fewer) had mean IQOL change scores that
were 5 points better than those who reported no improve-
ment in incontinence episodes.20,27
The outcome variable for the falls analysis was change
in FES, a measure of participant concern for falls during 10
daily activities (e.g., bathing, walking around the neigh-
borhood).21 Responses ranged from least (1 point) to most
concerned (4 points), yielding a final score with a range
from 10 to 40.29 A higher FES score indicates greater fear of
falling, and the FES is associated with future falls and dis-
ability.8,21,24–26 To facilitate interpretation of results, the
change scores for the falls analysis were calculated as base-
line FES score minus follow-up FES score, so a positive
change score indicated improvement in the falls condition
(i.e., less concern about falls over time). The analytical
sample for falls included participants with two or fewer
missing FES items. Multiple imputation was used to obtain
complete FES scores for 16 baseline and 18 follow-up
interviews with two or fewer missing items. Minimally
important effect sizes for this version of the FES were not
available, so to put the FES score into clinical perspective,
the findings from an intensive controlled multidisciplinary
home visit intervention that reduced risk of falls by 23%
were examined. The pre–post difference in FES scores
between the intervention and control groups was 1.4 FES
points (10.2 points vs  1.2 points, P 5.02).9
Predictor Variables
QI Measurement
The ACOVE-2 process-of-care quality indicators (QIs)
have been described previously in full,19 and the QIs (Tables
2 and 3) and scoring methods are briefly outlined here.
Participants with bothersome UI were eligible for three QIs
for UI diagnosis (taking a UI-specific history, examination,
and urinalysis, Table 2 QIs 1–3) and three QIs concerning
treatment (checking postvoid residual, discussing treatment
options, and recommending behavior intervention before
pharmacological treatment, QIs 4–6). A participant who
had fallen (twice in the past year or once with injury
requiring medical attention) was considered to need a fall-
specific history (Table 3, QI 1) and a gait and balance
examination (QI 2). A participant who had not fallen but
reported fear of falling was considered to need only a gait
and balance examination (QI 3). If physical examination
demonstrated abnormal balance, participants were eligible
for treatment with physical therapy or assistive device (QI
Table 1. Sample Characteristics
Characteristic Falls Sample (n 5 328) UI Sample (n 5 133)
Age, mean 80.6 80.1
Male, % 32.6 18.0
FES (10–40) or IQOL score (0–100), mean  SD 19.3  7.5 75.1  20.3
Number of falls or UI quality indicators triggered, mean  SD 1.8  1.0 4.9  0.6
Time between FES or IQOL measurements, months, mean (range) 10.4 (4.2–17.0) 9.8 (4.2–14.6)
Number of all ACOVE-2 quality indicators triggered across all medical and geriatric conditions
(a proxy for comorbidity), mean  SD (range)
12.0  4.3 (5–27) 14.8  4.0 (9–27)
Received care from an intervention site, % 54.6 54.9
Overall pass rate for falls or UI, mean  SD 31.3  39.7 32.6  29.9
Assessing the Care of Vulnerable Elders Study 2 (ACOVE-2) participants qualified for 98 indicators based on their comorbid conditions. In addition to falls and
urinary incontinence (UI), it included care pertaining to continuity of care, dementia, depression, diabetes mellitus, end of life, hearing loss, heart failure,
hypertension, ischemic heart disease, malnutrition, medication use, osteoarthritis, osteoporosis, pain management, pneumonia, pressure ulcers, preventive care,
stroke, and vision.
IQOL 5 Incontinence Quality of Life; FES 5 Falls Efficacy Scale; SD 5 standard deviation.
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4); if abnormal gait was found, participants were eligible
for physical therapy (QI 5).
Evaluation of individual QIs was performed using all
outpatient primary care and specialist medical records for a
13-month observation period for each participant. If the
participant received the recommended care process, a score
of 1 was awarded; if the process was not performed, a score
of 0 was assigned. If the participant refused recommended
care, full credit was awarded. Selected QIs (Falls QIs 3–5)
were excluded from application to individuals with
advanced dementia or life expectancy of 6 months or less.30
In addition, if the participant was documented in the med-
ical record as having received an examination and com-
pleted recommended therapies for UI or falls (referred to as
maximal treatment), QIs for that condition were excluded.
Finally, participants who described fear of falling but did
not fall before or during the observation period were ex-
cluded if they denied concern for falling on the FES.
Summary Quality Scores (Simple and
Common Pathway)
For this participant-level analysis, summary quality scores
were developed for each participant based on the individual
QIs measured in ACOVE-2. A simple summary score was
first calculated for each participant for falls, UI care, or
both, calculated as the number of QIs passed divided by the
number of QIs triggered, ranging from 0 to 100%.
Simple summary scores for participants with UI
were based on four to six UI QIs per participant, but in
contrast to the UI analysis, most of the falls sample (82%)
triggered only one or two QIs. This smaller number of
falls QIs per participant was a result of specific eligibility
criteria for the treatment QIs (4 and 5). An abnormal
gait or balance examination triggered these QIs, so partic-
ipants had to pass an examination QI (2 or 3) as a prereq-
uisite. Because two-thirds of the falls sample (224/328)
were not examined, few participants overall were evaluated
for care related to treatment. Considering the care of falls
as a pathway from diagnosis to treatment, the simple
summary scores for falls insufficiently captured the full
pathway of care quality for this sample. Therefore an
alternative scoring method that would restore evaluation
of treatment for this participant-level analysis was
proposed. Because the physical status of the unexamined
participants was not known, which treatment indicators
participants would be eligible for was ambiguous: QI 4
for balance problem, QI 5 for strength problem, both
problems, or no problem. QIs 4 and 5 were combined
into a single Common Pathway QI (CPQI) (Table 3, 3
rightmost columns). Participants who did not receive
an examination were presumed to have an undetected
physical problem and were scored accordingly on the
CPQI. Those who were examined and found to have an
abnormality (n 5 58) triggered one CPQI instead of
QI 4, QI 5, or both. The overall effect of employing the
Table 2. Relationship Between Incontinence Quality of Life (IQOL) Change Score and Whether Individual Urinary
Incontinence (UI) Quality Indicators (QIs) Were Passed or Failed
QI UI Quality Indicator








Passed Failed Passed Failed Passed Failed Passed Failed
1 If a person aged 75 and older reports new UI
symptoms, then a targeted history should be
performed.
 0.2 (38)  4.8 (95)  2.1 (38)  3.5 (95) 10.5 (38)  6.5 (95) 13.3 (38)  3.8 (95)
2 If a person aged 75 and older reports new UI
symptoms, then a targeted examination should be
performed.
11.7 (38)  5.4 (95) 10.2 (38)  4.4 (95)  0.6 (38)  6.6 (95) 16.0 (38)  4.9 (95)
3 If a person aged 75 and older reports new UI
symptoms, then a urinalysis should be performed.
 1.3 (49)  4.6 (84)  0.2 (49)  4.8 (84)  2.6 (49)  5.6 (84)  0.7 (49)  2.4 (84)
4 If a person aged 75 and older is found to have UI at a
new evaluation, and pharmacological therapy is
recommended, then a postvoid residual should be
performed before pharmacological therapy.
 0.5 (8)  4.2 (14) 13.9 (8)  4.0 (14)  4.9 (8)  7.5 (14) 14.5 (8) 11.4 (14)
5 If a person aged 75 and older is found to have UI at a
new evaluation, then treatment options should be
discussed.
 0.7 (57)  5.4 (76) 10.2 (57)  5.6 (76)  2.4 (57)  6.1 (76) 10.9 (57)  3.8 (76)
6 If a person aged 75 and older who is cognitively
intact and ambulatory is found to have UI without
hematuria or high postvoid residual, then behavioral
therapy should be recommended before
pharmacological therapy.
 2.7 (25)  6.0 (71)  1.6 (25)  5.2 (71)  4.5 (25)  7.4 (71)  1.0 (25)  4.6 (71)
The IQOL score and each subscale range is 0–100 (higher 5 better quality of life or fewer symptoms). A higher IQOL change score indicates improvement (or less
worsening) of IQOL.
Po .05,  .10 for unadjusted t-test of IQOL change score between patients who failed versus those who passed QI.
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CPQI was that all participants except those who had nor-
mal physical examinations were evaluated for at least one
treatment QI (n 5 66 without gait, strength, or balance




For each of the individual falls and UI QIs, the mean IQOL
and FES change scores of those who passed were compared
with the scores of those who failed the QI under consid-
eration. For falls, QIs 4 and 5 were evaluated separately and
then according to the CPQI described above. Two tailed
t-tests were performed to compare mean IQOL and FES
scores.
Participant-Level Tests
Next, the relationship between participants’ summary UI or
falls quality scores and IQOL or FES change scores, re-
spectively, were tested using unadjusted linear regression.
Multivariable regressions were then performed, controlling
for the following variables, chosen because of their poten-
tial effect on clinical outcomes: age, sex, number of ACOVE
indicators triggered for all conditions (a proxy measure of
comorbidity), and time between interviews. To address
confounding according to disease severity, number of UI or
falls QIs triggered was controlled for (for each analysis).
Whether the participant received care at an intervention
versus control practice was also controlled for, and an
interaction term between quality of care and intervention
assignment was tested. Because 36 primary care physicians
performed participants’ care, final multivariable models
were modeled as hierarchical random effects models, with
participants clustered within physicians.
For UI analyses, change in overall IQOL scores and
change in the three subdomain scores were considered to be
the main outcomes. For the falls analyses, all analyses were
performed using the simple summary score and the
CPQI methods. Final results were retested for sensitivity
to imputed scores by limiting the sample to those with
complete IQOL and FES scores. Intercooled Stata version
11.0 (Stata Corp., College Station, TX) was used for all
statistical analyses.
RESULTS
Of 2,671 individual aged 75 and older who were screened
for UI and falls or fear of falling, 235 (9%) answered
positively for new or bothersome UI symptoms, 500 (19%)
answered positively for fear of falls or falling (Figure 1),
and 115 (4.3%) answered positively for UI and falls or fear
of falling. For the UI sample, 32 (14%) were unable
to complete the baseline IQOL surveys, and another 40
(20%) were lost to follow-up or had incomplete follow-up
IQOL surveys. During quality measurement for UI care, 30
individuals (18%) were excluded based on ACOVE QI cri-
teria. The analytical sample for the UI analysis was 133
individuals evaluated for 650 UI QIs. For the falls sample,
89 (18%) individuals were excluded because of missing
baseline FES surveys and 66 (16%) because of missing
follow-up or incomplete FES surveys. Of the remaining
345 individuals, 17 were not evaluated for falls quality
based on ACOVE QI criteria. The analytical sample for
Table 3. Relationship Between Falls Efficacy Scale (FES) Change Score and Whether Individual Falls Quality Indicators
(QIs) Were Passed or Failed
FES Change Score (N, Number Who Trigged QI)
QI Falls Quality Indicator
Original Method
Common Pathway’’ Criteria
for QIs 4 and 5w
Passed Failed Passed Failed
1 If a person aged 75 and older reports a fall, then a falls history should be
performed.
1.8 (62) 1.6 (82) 1.8 (62) 1.6 (82)
2 If a person aged 75 and older reports a fall, then a falls physical examination
should be performed.
3.3 (56) 0.6 (88) 3.3 (56) 0.6 (88)
3 If a person aged 75 and older reports fear of falling or a gait, mobility, or balance
problem, then he or she should have a gait, mobility, and balance examination.
0.7 (68) 0.3 (153) 0.7 (68) 0.3 (153)
4 If a person aged 75 and older is found to have impaired balance, proprioception,
or increased postural sway, then an intervention (exercise or physical therapy,
assistive device) should be recommended.
4.1 (7) 3.1 (30) 3.9 (30) 0.7 269
5 If a person aged 75 and older is found to have impaired gait or decreased
strength or endurance, then an exercise program should be recommended.
4.3 (26) 1.7 (7)
The FES score ranges from 10–40 points. For ease of interpretation, the FES change scores in this analysis have been presented so that a higher FES change score
indicates more improvement in FES.
Po.05, two-tailed t-test on change scores between patients who failed and those who passed QI.
wThe common pathway scoring method combines QIs 4 and 5 into a common QI (resulting in 12 fewer eligible cases) and makes participants without
documented falls examinations eligible for the new combined treatment QI (resulting in 241 additional eligible cases).
For QI 2, the falls physical examination required at least three of the following five components: gait, balance, orthostatic blood pressure measurement, vision
(any element or vision specialist referral), and neurological examination (any element or neurologist referral).
Falls QIs could be triggered more than once, so the number of participants was slightly lower than the number of QIs triggered. The number of participants who
passed versus failed were 60 versus 81 for QI 1, 54 versus 87 for QI 2, 66 versus 152 for QI3, 7 versus 29 for QI 4, 25 versus 7 for QI 5, and 29 versus 247 for the
common pathway QI.
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the falls analysis was 328 participants who were evaluated
for 579 QIs. The mean follow-up time was 9.8 months
(range 4.2–14.6) for UI and 10.4 months (range 4.2–17.0)
for falls. The final analyses contained 55 participants (41%
of the UI sample and 17% of the falls sample) who were
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Figure 2. Predicted participant-reported urinary incontinence (UI) and falls outcomes in relation to UI and common pathway falls
quality scores. The Incontinence Quality of Life Score (QOL) ranges from 0 to 100. On this figure, a higher IQOL change score (higher
on the y-axis) corresponds to more improvement (or less worsening if a negative number). A 5–percentage point difference in IQOL
was correlated in a past study of incontinence outcomes with those who reported at least 25% improvement in incontinence episode
frequency.27 The Falls Efficacy Scale (FES) score ranges from 10 to 40. On this figure, a higher FES change score (higher on the y-axis)
corresponds to more improvement (or less worsening if a negative number). A 1.4-point difference in scores was reported in a prior
multipronged intervention to prevent falls.9 Both regression models are controlled for age, sex, number of falls or UI QIs, number of
Assessing Care of Vulnerable Elders Study-2 (ACOVE-2) QIs (a proxy for overall level of comorbidity), time difference, and fixed
effects of primary care physician. The falls analysis employed the Common Pathway Quality Indicator (CPQI) scoring method that
combined the two falls treatment QIs into a single QI (expanded to include all participants regardless of whether a falls examination
was performed, and passed if either treatment was recommended). An interaction term between quality score and intervention effect
was tested and retained in the falls model (less effect in the intervention group, P 5.10) but not the UI model (P 5.8). 95% confidence
intervals are the 5th and 95th percentile predicted scores obtained by bootstrapping the multiple imputed data 1,000 times. Predicted
FES and IQOL change scores are for an 80-year-old woman (modal sex) receiving care at a control practice over the mean observation
time (9.8 months for UI, 10.4 months for falls), the mean number of falls or UI QIs triggered (4 for UI, 3 for falls), and the mean
number of QIs triggered for all ACOVE-2 conditions (38 for UI, 22 QIs for falls). The arrows correspond to the mean quality scores
achieved in the ACOVE-2 intervention for intervention versus control groups. The improvement in the CPQI score for falls (20%
intervention, 40% control) was associated with a response of 0.8 FES points, whereas the improvement in UI quality score (23% vs
41%) was associated with a response of 2.5 IQOL points.
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Relationship Between Process and Outcome for UI
The mean age of the UI sample was 80. Four-fifths were
female, and mean baseline IQOL score was 87. On average,
participants worsened with respect to their UI symptoms
over the 10-month observation window. This was consis-
tent when measuring change in overall IQOL score (mean
decline of 3.4  16.3 points (P 5.02) and two of the three
subscales (avoidance behavior: mean decline 3  17.7
points, P 5.045; psychological quality of life: mean decline
1.6  18.6 points, P 5.006)). There was a nonsignificant
decline of 1.8  18.8 points (P 5.3) for the embarrassment
subscale.)
The unadjusted relationship between change in IQOL
score and whether individual UI QIs were passed or failed is
displayed in Table 2. For each of the six QIs, the direction of
effect was positive (i.e., the mean IQOL change score was
better for those who passed than those who failed), but
only QI 1 was associated with statistically significant
(t-test Po.05) improvement in overall IQOL and QI 2
with subscale change scores.
The mean summary UI quality score was
32.6  29.9%, with a mean score of 40.6% in the inter-
vention group versus 23.0% in the control group. A 10%
increment in unadjusted participant-level composite UI
quality score was associated with an improvement in over-
all IQOL score of 1.23 points (P 5.01) and improvement in
two of the three subdomain scores (avoidance 1.06, P 5.07;
psychological 1.30, P 5.03; embarrassment 1.41,
P 5.001).
Multivariable random-effects models (controlling for
age, sex, comorbidity, intervention group, and time
between interviews) showed that better UI quality was as-
sociated with improvement in UI-related quality of life. An
improvement of 10 percentage points in UI quality was in-
dependently associated with a 1.4-point improvement
(P 5.01) in the overall IQOL score and two subscales
(embarrassment, b5 1.6, P 5.008; psychological, b5 1.5,
P 5.02). There was no significant interaction between qual-
ity of care and group status (intervention vs control) in
predicting any of the UI outcomes (P 5.6–.8). Results were
robust to limiting the sample to those with complete IQOL
scores (n 5 120).
The predicted outcomes were calculated for a hypo-
thetical 80-year-old woman over the full range of quality of
care delivered in this study (Figure 2, upper graph) using the
final multivariable fixed-effects model. Providing none,
half, or all recommended care for UI was predicted to result
in a 7-point decrease, no change, and 7-point improvement,
respectively, in IQOL score over a mean 10-month follow-
up. Applying these results to a group-level clinical practice
improvement scenario, the expected improvement in mean
IQOL for a group of older individuals after improving UI
care from 23% to 41% of recommended care (the mean
summary scores for intervention vs control groups in the
ACOVE-2 study) would be 2.5 IQOL points, a small but
validated improvement in global UI symptoms.20,27
Relationship Between Process and Outcome for Falls
The mean age of the falls sample was 81. Three-quarters
were female, and mean baseline FES score was 19  7.5.
Over the 10-month observation period, the overall change
in concern for falling as measured according to FES score
was essentially unchanged (mean improvement of 0.6  6.7
points, P 5.1).
The unadjusted relationship between change in FES
scores and individual falls QIs was tested (Table 3). For each
QI, mean improvement in FES change score was greater for
subjects passing the QI than for those failing the QI, but
statistical significance (Po.05) was associated only with
performing a falls examination (QI 3, 3.3- vs 0.6-point
improvement, P 5.03) and the CPQI (3.9- vs 0.7-point
improvement, P 5.02).
Most of the participants in the sample (n 5 292,
89.0%) had a single fall or fear of falling event, triggering
one to four QIs (mean 1.5) according to the simple scoring
method and one to three QIs (mean 2.2) according to the
CPQI method instead of separate QIs 4 and 5. Thirty-six
people (11.0%) had two or more events. The mean simple
summary falls score was 31.3% (39.8% in the intervention
group, 21.0% in the control group) and slightly lower using
the CPQI method (30.3% overall mean, 39.2% interven-
tion, 19.6% control). Neither the simple nor the CPQI score
was related to unadjusted FES change scores (for both
scores, b5 0.12 per absolute 10-percentage point improve-
ment in quality, P 5.2).
However, the multivariable random-effects analyses
showed that the CPQI score was related to better FES
change score (b5 0.41 FES points per 10-percentage point
increment in quality, P 5.01), whereas the simple summary
score was not (b5 0.21, P 5.20). Predicted outcomes for
the CPQI model are displayed in Figure 2 (lower graph). For
an 80-year-old woman, providing 0%, 50%, or 100% of
the recommended care would result in an improvement of
0.4, 2.4, and 4.5 FES points, respectively, over the 10-
month follow up period. Applying these results to a clinical
practice quality improvement scenario, an improvement
from 20% to 40% of recommended care would be expected
to result in mean improvement of 0.8 FES points. This
response was approximately two-thirds of the improvement
in FES (1.4 points) associated with a multidisciplinary
home-based controlled intervention to decrease falls.9
Results of the falls analysis were also robust to limiting
the sample to those with complete FES scores (n 5 312).
DISCUSSION
In this secondary analysis of the ACOVE-2 practice-based
quality improvement study, it was hypothesized that
better adherence to evidence-based QIs would improve
participant-reported outcomes for falls and UI. A small but
clinically meaningful improvement in incontinence quality-
of-life (2.5 points) was found over 10 months in response to
a 15–percentage point quality improvement for UI, a
realistic level of improvement in quality that was achieved
in the ACOVE-2 practice-based intervention.19 The IQOL
response observed in this analysis corresponds to prior
studies of people with UI with a small improvement in
global self-reported UI symptoms and half the improvement
of those with a substantial decrease in incontinent episode
frequency.20,27 A small improvement in falls efficacy
(0.8-point improvement in the FES) associated with better
quality of care for falls was also found (the 20–percentage
point improvement achieved in the ACOVE-2 study). The
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response observed was approximately two-thirds the effect
on FES found in an intensive home-based falls-reduction
intervention.9
The results of the current study shed further light on
understanding of ambulatory care for geriatric conditions.
For falls and UI, the analysis extends prior interventional
research by measuring the full spectrum of office-based care
that includes diagnostic processes (history taking and physical
examination) and treatment. In this study, the broader prac-
tice-based approach was modestly linked with better out-
comes although not as tightly linked as in clinical intervention
trials that improved falls efficacy9,13,31,32 and incontinence7–
16 (e.g., pharmacological or behavioral therapy).
Although the individual QI-level falls scores appeared
to be positively related to better FES, the participant-level
simple summary score was not. The simple summary score
was an inadequate measure of comprehensive falls care
because so many individuals in the sample did not receive
physical examinations. For these individuals, gait and bal-
ance abnormalities could not be identified, and therefore
appropriate treatment could not be directed at improving
their falls outcomes. These results suggest that the associ-
ation between process and participant-level outcomes for
falls was restored by scoring with the CPQI, which assigned
those without a physical examination an additional penalty
for failure to treat. To the knowledge of the authors, this is
the first report to test an alternative scoring method that
addresses serial care measures in which failing to perform
an early care process results in exclusion from eligibility for
downstream QIs. The CPQI scoring modification addresses
this problem, emphasizing the importance of performing
high-quality comprehensive care from screening to diagno-
sis to treatment to follow-up. These findings regarding falls
care demonstrate that participant-level quality measures
obfuscate detection of poor comprehensive care and should
be avoided in future QI design.
Although the ACOVE-2 intervention improved UI and
falls quality of care at two intervention clinical practices,19
there remained substantial room for improvement. The
quality of care delivered to individual participants was a
better predictor of participant-reported UI- and falls-related
outcomes than whether a participant was seen at an inter-
vention or a control practice.
IQOL scores of the UI sample as a whole worsened over
the short follow-up interval (10 months), which was
inconsistent with other studies that have found better
IQOL scores as people age and adapt to their UI symp-
toms.20 Rather than improving the quality of life for the
sample, it appears that better quality of care attenuated a
natural decline that occurred in the sample over 10 months,
with only a small subset of participants (those with 475%
of indicators passed) experiencing symptom improvement.
The decline in IQOL may reflect the advanced age of the
sample, which contrasts with prior IQOL studies that fo-
cused on younger populations. Some individuals in this
older sample may also have thought that their symptoms
were a normal part of aging at baseline but developed more
concern about symptoms as a result of increased labeling
and medical attention.33
A strength of the study design is that clinically detailed
quality-of-care data on older outpatients were used that are
not available in administrative data sets. Measures of con-
dition-specific symptom severity were also administered
before and after the delivery of care. The data were col-
lected prospectively in a community-based sample of older
participants with falls and UI symptoms, although the find-
ings should be viewed in light of the limitations of the
ACOVE-2 sample, which was not ethnically diverse and
was assembled from only two medical groups. The results
also cannot be generalized to individuals who cannot self-
report their FES or IQOL. Clinical outcomes were not col-
lected in the ACOVE-2 study, for example, frequency and
severity of subsequent falls and number of incontinence
episodes. Clinical severity measures would complement
participant-reported outcomes in future quality improve-
ment studies.
In conclusion, the current study found that the quality of
care for falls and UI was associated with improvement in falls
efficacy and UI-related quality of life. The link between better
primary care for these conditions and better outcomes should
provide impetus for strengthening efforts to enhance care of
these conditions within primary care practices.
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